BioMarin: 4Q Earnings Snapshot

SAN RAFAEL, Calif. (AP) _ BioMarin Pharmaceutical Inc. (BMRN) on Thursday reported a loss of $3.7 million in its fourth quarter.

The San Rafael, California-based company said it had a loss of 3 cents per share. Losses, adjusted for one-time gains and costs, were 6 cents per share.

The results missed Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of 10 cents per share.

The rare disease biopharmaceutical posted revenue of $353.2 million in the period, which also missed Street forecasts. Eleven analysts surveyed by Zacks expected $379.7 million.

For the year, the company reported that its loss narrowed to $77.2 million, or 44 cents per share. Revenue was reported as $1.49 billion.

BioMarin expects full-year revenue in the range of $1.68 billion to $1.75 billion.

BioMarin shares have climbed slightly more than 4 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $88.81, a rise of 5.5 percent in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BMRN at https://www.zacks.com/ap/BMRN